Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Mutti

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Psychopharmacology|September 22, 2015
Pharmacological and non-pharmacological factors that regulate the acquisition of ketamine self-administration in ratsMarco Venniro, Anna Mutti, Cristiano Chiamulera
Behavioural Pharmacology|February 12, 2016
The ketamine analogue methoxetamine generalizes to ketamine discriminative stimulus in ratsCristiano Chiamulera, Federica Armani, Anna Mutti, et al.
Behavioural Pharmacology|September 18, 2014
Nicotine-seeking reinstatement is reduced by inhibition of instrumental memory reconsolidationVincenzo Tedesco, Anna Mutti, Alessia Auber, et al.
Epilepsy Research|October 5, 2023
Dimethyl sulfoxide's impact on epileptiform activity in a mouse model of chronic temporal lobe epilepsyMelanie Widmann, Andreas Lieb, Anna Mutti, et al.
Experimental Neurology|March 11, 2024
Characterization of the intrahippocampal kainic acid model in female mice with a special focus on seizure suppression by antiseizure medicationsMelanie Widmann, Andreas Lieb, Barbara Fogli, et al.
Frontiers in Pharmacology|November 14, 2024
Structure-function relationship of dynorphin B variants using naturally occurring amino acid substitutionsLuca Zangrandi, Barbara Fogli, Anna Mutti, et al.
Journal of Molecular Biology|February 15, 2025
A combined in silico approach to design peptide ligands with increased receptor-subtype selectivityAdam Zech, Victoria Most, Anna Mutti, et al.
Psychopharmacology|March 30, 2016
The ketamine-like compound methoxetamine substitutes for ketamine in the self-administration paradigm and enhances mesolimbic dopaminergic transmissionAnna Mutti, Sonia Aroni, Paola Fadda, et al.
EMBO Molecular Medicine|September 6, 2019
Dynorphin-based "release on demand" gene therapy for drug-resistant temporal lobe epilepsyAlexandra S Agostinho, Mario Mietzsch, Luca Zangrandi, et al.
Pharmacological Research|December 27, 2015
The modulation of BDNF expression and signalling dissects the antidepressant from the reinforcing properties of ketamine: Effects of single infusion vs. chronic self-administration in ratsLucia Caffino, Marzia Di Chio, Giuseppe Giannotti, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Psychopharmacology|September 22, 2015
Pharmacological and non-pharmacological factors that regulate the acquisition of ketamine self-administration in ratsMarco Venniro, Anna Mutti, Cristiano Chiamulera
Behavioural Pharmacology|February 12, 2016
The ketamine analogue methoxetamine generalizes to ketamine discriminative stimulus in ratsCristiano Chiamulera, Federica Armani, Anna Mutti, et al.
Behavioural Pharmacology|September 18, 2014
Nicotine-seeking reinstatement is reduced by inhibition of instrumental memory reconsolidationVincenzo Tedesco, Anna Mutti, Alessia Auber, et al.
Epilepsy Research|October 5, 2023
Dimethyl sulfoxide's impact on epileptiform activity in a mouse model of chronic temporal lobe epilepsyMelanie Widmann, Andreas Lieb, Anna Mutti, et al.
Experimental Neurology|March 11, 2024
Characterization of the intrahippocampal kainic acid model in female mice with a special focus on seizure suppression by antiseizure medicationsMelanie Widmann, Andreas Lieb, Barbara Fogli, et al.
Frontiers in Pharmacology|November 14, 2024
Structure-function relationship of dynorphin B variants using naturally occurring amino acid substitutionsLuca Zangrandi, Barbara Fogli, Anna Mutti, et al.
Journal of Molecular Biology|February 15, 2025
A combined in silico approach to design peptide ligands with increased receptor-subtype selectivityAdam Zech, Victoria Most, Anna Mutti, et al.
Psychopharmacology|March 30, 2016
The ketamine-like compound methoxetamine substitutes for ketamine in the self-administration paradigm and enhances mesolimbic dopaminergic transmissionAnna Mutti, Sonia Aroni, Paola Fadda, et al.
EMBO Molecular Medicine|September 6, 2019
Dynorphin-based "release on demand" gene therapy for drug-resistant temporal lobe epilepsyAlexandra S Agostinho, Mario Mietzsch, Luca Zangrandi, et al.
Pharmacological Research|December 27, 2015
The modulation of BDNF expression and signalling dissects the antidepressant from the reinforcing properties of ketamine: Effects of single infusion vs. chronic self-administration in ratsLucia Caffino, Marzia Di Chio, Giuseppe Giannotti, et al.
Pageof 2